Principal Financial Group
MBII

Principal Financial Group’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Principal Financial Group’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-20,023
Closed -$22K – 2711
2022
Q1 		$22K Buy
20,023
+2,646
+15% +$2K ﹤0.01% 2521
2021
Q4 		$13K Sell
17,377
-1,947
-10% -$1.57K ﹤0.01% 2518
2021
Q3 		$17K Buy
19,324
+3,306
+21% +$3.98K ﹤0.01% 2572
2021
Q2 		$27K Buy
16,018
+4,399
+38% +$7.35K ﹤0.01% 2595
2021
Q1 		$24K Sell
11,619
-903
-7% -$1.88K ﹤0.01% 2476
2020
Q4 		$16K Buy
12,522
+2,372
+23% +$2.83K ﹤0.01% 2413
2020
Q3 		$12K Sell
10,150
-712
-7% -$866 ﹤0.01% 2319
2020
Q2 		$13K Buy
+10,862
New +$10K ﹤0.01% 2314
2014
Q3 		– Sell
-180,000
Closed -$2.09M – 2253
2014
Q2 		$2.09M Buy
180,000
+57,500
+47% +$652K ﹤0.01% 1672
2014
Q1 		$1.71M Sell
122,500
-2,100
-2% -$33K ﹤0.01% 1681
2013
Q4 		$2.21M Buy
124,600
+1,600
+1% +$26K ﹤0.01% 1646
2013
Q3 		$2.07M Buy
+123,000
New +$1.73M ﹤0.01% 1622

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

Principal Financial Group's MBII Position: Q2 2022 in Review

Principal Financial Group sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2022, closing a stake of 20,023 shares — an estimated $22K sold.

Principal Financial Group first reported a position in MBII in Q3 2013 and held it in 12 quarters. The position peaked at $2.21M in Q4 2013. 62 funds tracked by Wall St. Rank hold MBII as of Q2 2022.

  • Principal Financial Group reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2022 after selling out during the quarter.
  • Principal Financial Group sold 20,023 Marrone Bio Innovations, Inc. shares in Q2 2022, an estimated $22K.
  • Principal Financial Group first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 12 quarters.
  • Principal Financial Group's Marrone Bio Innovations, Inc. position peaked at $2.21M in Q4 2013.
  • 62 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2022.

Based on Principal Financial Group's 13F filing for Q2 2022, filed 10 Aug 2022.